Attrition in metastatic breast cancer: a metric to be reported in randomised clinical trials?

Imperia Nuzzolese, Filippo Montemurro

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)21-24
Number of pages4
JournalThe Lancet. Oncology
Volume21
Issue number1
DOIs
Publication statusPublished - Jan 2020

Keywords

  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Breast Neoplasms/drug therapy
  • Female
  • Humans
  • Lost to Follow-Up
  • Patient Dropouts/psychology
  • Randomized Controlled Trials as Topic

Cite this